D. Cha

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

The effect of lisdexamfetamine dimesylate on body weight, metabolic parameters, and attention deficit hyperactivity disorder symptomatology in adults with bipolar I/II disorder

S. Kennedy, R. McIntyre, D. Cha, 2013, Human psychopharmacology.

Characterizing, Assessing, and Treating Cognitive Dysfunction in Major Depressive Disorder

Nelson B Rodrigues, Nicole E. Carmona, R. McIntyre, 2018, Harvard review of psychiatry.

Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder.

Nicole E. Carmona, B. Baune, R. Lam, 2017, Journal of affective disorders.

The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive Disorder.

Larry Culpepper, Raymond W Lam, Mehala Subramaniapillai, 2017, The Journal of clinical psychiatry.

A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder.

B. Sahakian, S. Kennedy, R. McIntyre, 2017, Journal of affective disorders.

The Prevalence, Measurement, and Treatment of the Cognitive Dimension/Domain in Major Depressive Disorder

A. Carvalho, R. McIntyre, M. Vinberg, 2015, CNS Drugs.

Changes in symptoms of anhedonia in adults with major depressive or bipolar disorder receiving IV ketamine: Results from the Canadian Rapid Treatment Center of Excellence.

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Journal of affective disorders.

Obesity and Mental Illness: Implications for Cognitive Functioning

R. McIntyre, V. Taylor, J. Jerrell, 2013, Advances in Therapy.

Metformin: repurposing opportunities for cognitive and mood dysfunction.

A. Carvalho, R. McIntyre, D. Cha, 2015, CNS & neurological disorders drug targets.

Neuroscience and Biobehavioral Reviews Potential Roles of Zinc in the Pathophysiology and Treatment of Major Depressive Disorder

R. McIntyre, N. Herrmann, W. Swardfager, 2022 .

Parsing metabolic heterogeneity in mood disorders: A hypothesis‐driven cluster analysis of glucose and insulin abnormalities

R. McIntyre, D. Cha, E. Brietzke, 2020, Bipolar disorders.

Sex differences in rates of obesity in bipolar disorder: postulated mechanisms

R. McIntyre, D. Cha, Anusha Baskaran, 2014, Bipolar disorders.

Treatment-emergent adverse events associated with atypical antipsychotics

R. McIntyre, D. Cha, 2012, Expert opinion on pharmacotherapy.

Inflamed moods: A review of the interactions between inflammation and mood disorders

R. McIntyre, J. Rosenblat, D. Cha, 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Psychopharmacology.

Gut emotions - mechanisms of action of probiotics as novel therapeutic targets for depression and anxiety disorders.

A. Carvalho, S. Kasper, R. McIntyre, 2015, CNS & neurological disorders drug targets.

Evaluating the neural substrates of effort-expenditure for reward in adults with major depressive disorder and obesity

Nelson B Rodrigues, C. Hawco, R. McIntyre, 2023, Psychiatry Research: Neuroimaging.

The impact of overweight/obesity on monetary reward processing: A systematic review.

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Journal of psychiatric research.

The mechanism, efficacy, and tolerability profile of agomelatine

A. Carvalho, R. McIntyre, D. Cha, 2014, Expert opinion on pharmacotherapy.

Predominant polarity as a course specifier for bipolar disorder: a systematic review.

A. Carvalho, R. McIntyre, M. Berk, 2014, Journal of affective disorders.

Predicting Treatment Response in Major Depressive Disorder: The Impact of Early Symptomatic Improvement

D. Cha, P. Kudlow, R. Mclntyre, 2012, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

The Association between Childhood Adversity and Components of Metabolic Syndrome in Adults with Mood Disorders: Results from the International Mood Disorders Collaborative Project

S. Kennedy, R. McIntyre, V. Taylor, 2012, International journal of psychiatry in medicine.

Sleep architecture variation: a mediator of metabolic disturbance in individuals with major depressive disorder.

R. Lam, R. McIntyre, D. Cha, 2013, Sleep medicine.

Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic review.

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Journal of affective disorders.

Selfish brain and neuroprogression in bipolar disorder

R. McIntyre, D. Cha, E. Brietzke, 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Progress in Neuro-Psychopharmacology & Biological Psychiatry

R. McIntyre, D. Cha, E. Brietzke, 2013 .

Implications of epigenetic modulation for novel treatment approaches in patients with schizophrenia

R. McIntyre, D. Cha, P. Kudlow, 2014, Neuropharmacology.

Stability, reliability, and validity of the THINC‐it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteers

Larry Culpepper, Raymond W Lam, John E Harrison, 2018, International journal of methods in psychiatric research.

Assessing and measuring cognitive function in major depressive disorder

R. McIntyre, J. Rosenblat, Ron Kakar, 2016, Evidence-Based Mental Health.

A review of published evidence reporting on the efficacy and pharmacology of lurasidone

R. McIntyre, J. Jerrell, D. Cha, 2012, Expert opinion on pharmacotherapy.

Crosstalk between metabolic and neuropsychiatric disorders

R. McIntyre, D. Cha, O. Kaidanovich‐Beilin, 2012, F1000 biology reports.

Is there a role for curcumin in the treatment of bipolar disorder?

A. Carvalho, R. McIntyre, A. Zugman, 2013, Medical hypotheses.

A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusions.

Nelson B Rodrigues, R. McIntyre, M. Vinberg, 2020, Journal of affective disorders.

Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Expert opinion on drug safety.

Strategies to mitigate dissociative and psychotomimetic effects of ketamine in the treatment of major depressive episodes: a narrative review

R. McIntyre, J. Rosenblat, Ron Kakar, 2017, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Sex differences in the mediators of functional disability in Major Depressive Disorder.

Nicole E. Carmona, R. McIntyre, D. Cha, 2018, Journal of psychiatric research.

Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of Excellence

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Major depressive disorder in breast cancer: a critical systematic review of pharmacological and psychotherapeutic clinical trials.

A. Carvalho, R. McIntyre, N. Pavlidis, 2014, Cancer treatment reviews.

The association between insulin resistance and depression in the Korean general population.

R. McIntyre, D. Cha, R. Mansur, 2017, Journal of affective disorders.

Brexpiprazole as an augmentation agent to antidepressants in treatment resistant major depressive disorder

R. McIntyre, D. Cha, J. Ahmed, 2019, Expert review of neurotherapeutics.

The Effect of Personality Dimensions on Functional Outcomes in Mood Disorders

S. Kennedy, R. McIntyre, R. Dale, 2013, Advances in Therapy.

Social Isolation, Loneliness and Generalized Anxiety: Implications and Associations during the COVID-19 Quarantine

Nelson B Rodrigues, R. McIntyre, D. Cha, 2021, Brain sciences.

Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder

R. McIntyre, J. Rosenblat, D. Cha, 2018, International journal of environmental research and public health.

Does pre-treatment functioning influence response to intravenous ketamine in adults with treatment-resistant depression?

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Journal of affective disorders.

The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorder

Nelson B Rodrigues, T. Suppes, A. Fagiolini, 2020, Bipolar disorders.

The emerging role of psilocybin and MDMA in the treatment of mental illness

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Expert review of neurotherapeutics.

Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in Major Depressive Disorder.

Nelson B Rodrigues, Nicole E. Carmona, R. McIntyre, 2018, Journal of affective disorders.

The prevalence and illness characteristics of DSM-5-defined "mixed feature specifier" in adults with major depressive disorder and bipolar disorder: Results from the International Mood Disorders Collaborative Project.

A. Carvalho, S. Kennedy, R. McIntyre, 2015, Journal of affective disorders.

Machine learning and big data: Implications for disease modeling and therapeutic discovery in psychiatry

Yena Lee, Roger S. McIntyre, Rodrigo B. Mansur, 2019, Artif. Intell. Medicine.

Treatment of cognitive dysfunction in adults with major depressive disorder

R. McIntyre, D. Cha, K. Syeda, 2016 .

Diabetes Mellitus and Disturbances in Brain Connectivity: A Bidirectional Relationship?

R. McIntyre, A. Zugman, D. Cha, 2014, NeuroMolecular Medicine.

Air pollution, aeroallergens and suicidality: a review of the effects of air pollution and aeroallergens on suicidal behavior and an exploration of possible mechanisms

Nicole E. Carmona, R. McIntyre, D. Cha, 2017, Reviews on environmental health.

The impact of cognitive impairment on perceived workforce performance: results from the International Mood Disorders Collaborative Project.

A. Carvalho, S. Kennedy, R. McIntyre, 2015, Comprehensive psychiatry.

A New Perspective on the Anti-Suicide Effects With Ketamine Treatment: A Procognitive Effect

R. McIntyre, J. Rosenblat, D. Cha, 2016, Journal of clinical psychopharmacology.

The prevalence and clinical characteristics associated with Diagnostic and Statistical Manual Version-5-defined anxious distress specifier in adults with major depressive disorder: results from the International Mood Disorders Collaborative Project

A. Carvalho, S. Kennedy, R. McIntyre, 2016, Therapeutic advances in chronic disease.

Binge eating in adults with mood disorders: Results from the International Mood Disorders Collaborative Project.

A. Carvalho, S. Kennedy, R. McIntyre, 2016, Obesity research & clinical practice.

Do sleep changes mediate the anti‐depressive and anti‐suicidal response of intravenous ketamine in treatment‐resistant depression?

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2021, Journal of sleep research.

Nitric Oxide and Major Depressive Disorder: Pathophysiology and Treatment Implications.

A. Carvalho, R. McIntyre, D. Cha, 2016, Current molecular medicine.

Perceived sleep quality predicts cognitive function in adults with major depressive disorder independent of depression severity.

Nicole E. Carmona, R. McIntyre, J. Rosenblat, 2019, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

Anhedonia and cognitive function in adults with MDD: results from the International Mood Disorders Collaborative Project

A. Carvalho, S. Kennedy, R. McIntyre, 2015, CNS Spectrums.

Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, CNS Spectrums.

Characterizing amino-acid biosignatures amongst individuals with schizophrenia: a case–control study

R. McIntyre, J. Rosenblat, D. Cha, 2018, Amino Acids.

Is binge eating a cognitive disorder? Results from the International Mood Disorders Collaborative Project.

Nicole E. Carmona, S. Kennedy, R. McIntyre, 2018, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

Cognitive Impairment in Major Depressive Disorder: Clinical Relevance, Biological Substrates, and Treatment Opportunities

R. McIntyre, D. Cha, 2016 .

Cognition in Major Depressive Disorder

R. McIntyre, D. Cha, J. Soczynska, 2014 .

Characterizing amino-acid biosignatures amongst individuals with schizophrenia: a case–control study

R. McIntyre, J. Rosenblat, D. Cha, 2018, Amino Acids.

‘Hot’ versus ‘cold’ cognition

R. McIntyre, D. Cha, J. Soczynska, 2014 .

Selfish brain and neuroprogression in bipolar disorder

R. McIntyre, D. Cha, E. Brietzke, 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Intravenous ketamine for postmenopausal women with treatment-resistant depression: Results from the Canadian Rapid Treatment Center of Excellence.

Nelson B Rodrigues, R. McIntyre, J. Rosenblat, 2020, Journal of psychiatric research.

A New Perspective on the Anti-Suicide Effects With Ketamine Treatment: A Procognitive Effect

R. McIntyre, J. Rosenblat, D. Cha, 2016, Journal of clinical psychopharmacology.

Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder.

Nicole E. Carmona, B. Baune, R. Lam, 2017, Journal of affective disorders.

The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive Disorder.

Nicole E. Carmona, C. Harmer, B. Baune, 2017, The Journal of clinical psychiatry.

Measuring the mind: detecting cognitive deficits and measuring cognitive change in patients with depression

R. McIntyre, D. Cha, J. Harrison, 2016 .

Implications of epigenetic modulation for novel treatment approaches in patients with schizophrenia

R. McIntyre, D. Cha, P. Kudlow, 2014, Neuropharmacology.

Strategies to mitigate dissociative and psychotomimetic effects of ketamine in the treatment of major depressive episodes: a narrative review

R. McIntyre, J. Rosenblat, Ron Kakar, 2016, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Repurposing of Anti-Diabetic Agents for the Treatment of Cognitive Impairment and Mood Disorders.

A. Carvalho, R. McIntyre, D. Cha, 2016, Current molecular medicine.

The efficacy of zuranolone in postpartum depression and major depressive disorder: a review & number needed to treat (NNT) analysis

J. Rosenblat, D. Cha, R. Mansur, 2024, Expert opinion on pharmacotherapy.

Pain and major depressive disorder: Associations with cognitive impairment as measured by the THINC-integrated tool (THINC-it)

Nelson B Rodrigues, Nicole E. Carmona, R. McIntyre, 2017, Scandinavian journal of pain.

A review of FDA-approved treatment options in bipolar depression

R. McIntyre, D. Cha, R. Mansur, 2013, CNS Spectrums.